Membership
Tour
Register
Log in
William L. Laswell
Follow
Person
Perkasie, PA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Sulfonamide fibrinogen receptor antagonists
Patent number
6,040,317
Issue date
Mar 21, 2000
Merck & Co., Inc.
Mark E. Duggan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Sulfonamide fibrinogen receptor antagonists
Patent number
5,880,136
Issue date
Mar 9, 1999
Merck & Co., Inc.
Mark E. Duggan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Sulfonamide fibrinogen receptor antagonists
Patent number
5,814,643
Issue date
Sep 29, 1998
Merck & Co., Inc.
Mark E. Duggan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Sulfonamide fibrinogen receptor antagonists
Patent number
5,658,929
Issue date
Aug 19, 1997
Merck & Co., Inc.
Mark E. Duggan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Fibrinogen receptor antagonists
Patent number
5,294,616
Issue date
Mar 15, 1994
Merck & Co., Inc.
Mark E. Duggan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Nitrogen deprotected 4-acyloxyazetidin-2-ones
Patent number
5,177,201
Issue date
Jan 5, 1993
Merck & Co., Inc.
Joseph E. Lynch
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R) 4-ar...
Patent number
5,145,957
Issue date
Sep 8, 1992
Merck & Co., Inc.
David M. Tschaen
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for the preparation of 4-acyloxyazetidin-2-one by electroch...
Patent number
4,952,288
Issue date
Aug 28, 1990
Merck & Co., Inc.
Joseph E. Lynch
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for the preparation of 4-acyloxyazetidin-2-one by singlet o...
Patent number
4,940,520
Issue date
Jul 10, 1990
Merck & Co., Inc.
Joseph E. Lynch
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Oxidation and reduction method to produce 4-acyloxyazetidin-2-one
Patent number
4,923,982
Issue date
May 8, 1990
Merck & Co., Inc.
Joseph E. Lynch
C07 - ORGANIC CHEMISTRY